Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106
Phase 1
Completed
- Conditions
- Overweight and Obesity
- Interventions
- Drug: GMA106 InjectionDrug: GMA106 Matching Placebo
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Gmax Biopharm Australia Pty Ltd.
- Target Recruit Count
- 73
- Registration Number
- NCT05054530
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers
Phase 1
Completed
- Conditions
- Pulmonary Arterial Hypertension
- Interventions
- Drug: GMA301 InjectionOther: GMA301 Placebo Injection
- First Posted Date
- 2020-08-10
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- Gmax Biopharm Australia Pty Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT04505137
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
News
No news found